Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

Thymosin Beta-4 + BPC-157 + SS-31 + GHK-Cu Eye Health Stack

A theoretical peptide combination discussed for ocular surface and retinal support — dry eye, corneal healing, and age-related mitochondrial stress in the eye. It is a mechanistic rationale drawn largely from preclinical and non-ocular data, not a clinically validated eye treatment, and eye symptoms should be evaluated by an ophthalmologist.

Quick Comparison

PropertypeptideThe Eye Health Stack: Thymosin Beta-4 + BPC-157 + SS-31 + GHK-Cu
SourceSalmon DNA fragmentsVarious sources
Primary MechanismA2A receptor activation, DNA repairVaries by ingredient
Key BenefitsTissue regeneration, anti-inflammation, collagen boostMultiple skin benefits
Best Time to ApplyAM or PMAM or PM
Can Combine?Generally compatible — check specific guidelines.

How to Use Together

No controlled trial has tested this combination for eye health, and the eye is a specialized, delicate organ where self-directed peptide use carries real risk. The most conventional formulations are ophthalmic (eye-drop) rather than systemic: Thymosin beta-4 has been studied as a preservative-free eye drop for corneal wound healing and dry eye in formal trials, and any use should follow that clinical route, not compounded home preparations. SS-31 (elamipretin) has been investigated as an eye drop and intravitreal agent in industry-run studies for retinal disease — it is not something to self-administer. BPC-157 and GHK-Cu appear in this stack on a purely mechanistic basis (tissue repair, angiogenesis modulation). Do not inject anything into or around the eye yourself; ocular administration belongs exclusively to trained clinicians. If you have dry eye or vision changes, start with a proper eye exam.

Safety Notes

The eye tolerates almost no error: contamination, wrong pH or osmolarity, or non-sterile preparation can cause corneal damage, infection, or permanent vision loss, so home-compounded ocular peptides are dangerous and strongly discouraged. Retinal conditions (macular degeneration, diabetic retinopathy, retinal vein occlusion) require diagnosis and monitoring by an ophthalmologist — delaying real treatment to trial peptides can cost vision. GHK-Cu near the eye raises copper-exposure and irritation concerns. SS-31 and thymosin beta-4 ocular applications remain investigational and have only been used in supervised clinical settings. None of these compounds is an approved consumer eye treatment; treat this stack as a research concept and let a specialist manage any actual eye disease.

Recommended Products (4)

Frequently Asked Questions

Can these peptides cure dry eye or retinal disease?
No. There is no proof that this combination cures or reliably treats any eye condition, and framing it that way would be misleading. Dry eye and retinal diseases have established, evidence-based treatments — from artificial tears, anti-inflammatory drops, and lifestyle measures to injections and procedures administered by ophthalmologists. This stack is a mechanistic idea drawn largely from preclinical and non-ocular data. Anyone with a genuine eye problem should be diagnosed and treated through an eye specialist rather than experimenting.
What is the rationale for using thymosin beta-4 for the eye?
Thymosin beta-4 has the most legitimate ocular story of the group: it has been studied as a preservative-free eye drop for promoting corneal wound healing and reducing inflammation in dry eye and neurotrophic keratitis in formal clinical research. Its mechanism involves supporting cell migration and reducing inflammatory signaling on the ocular surface. That said, these were controlled studies using pharmaceutical-grade, sterile formulations under medical supervision. It is not a reason to self-prepare eye drops, which is unsafe.
Is it safe to make my own peptide eye drops at home?
No, and this is the single most important safety point. The eye surface has essentially no tolerance for contamination, incorrect pH, wrong osmolarity, or non-sterile technique — errors can cause corneal ulcers, serious infection, or permanent vision loss. Sterile ophthalmic manufacturing exists precisely because the eye is so vulnerable. Any peptide intended for the eye must come from a properly compounded or manufactured sterile source and be used under an eye doctor's guidance. Home-mixing research powders into eye drops is genuinely dangerous.
What is SS-31 and why does it appear in an eye stack?
SS-31 (also called elamipretin) is a mitochondria-targeting peptide investigated for conditions where mitochondrial dysfunction contributes to disease, including some retinal disorders like dry age-related macular degeneration. It has been studied in industry-sponsored trials as an eye drop and as an intravitreal agent under strict clinical conditions. Its inclusion here reflects the theory that retinal cells are metabolically demanding and vulnerable to mitochondrial stress. However, its ocular use is investigational and confined to supervised research — it is not a self-administered supplement.
Has any trial tested this four-peptide combination for eyes?
No controlled trial has tested this specific combination for eye health. Individual components have separate research lines — thymosin beta-4 for corneal healing, SS-31 for retinal mitochondrial support — but combining all four is a community-level hypothesis, not a studied protocol. There is no synergy data, no combined safety data, and no dosing standard. You should interpret any online claims about this stack's eye benefits as speculative. Real ocular treatment decisions should rest on evidence and an ophthalmologist's assessment.
Could BPC-157 or GHK-Cu help with eye healing?
The rationale is indirect. BPC-157 is a repair peptide with mostly preclinical data in gut and connective tissue, and GHK-Cu modulates angiogenesis and tissue remodeling in skin — properties someone might extrapolate to ocular healing. But extrapolating from skin or gut to the eye is a large leap, and there is little to no controlled ocular evidence for either. GHK-Cu near the eye also raises copper-irritation concerns. Their inclusion is theoretical, and neither should be applied to the eye without ophthalmologic supervision.
I have age-related macular degeneration — should I try this instead of my prescribed treatment?
No, absolutely not. Age-related macular degeneration has real, evidence-based management — including AREDS2 supplementation for intermediate dry AMD and anti-VEGF injections for the wet form — and delaying or replacing that care to try unproven peptides can lead to irreversible vision loss. Any experimental agent should only ever be considered inside a formal clinical trial, if at all, and always alongside standard care directed by your retina specialist. Please keep your prescribed treatment and raise any interest in peptides directly with your ophthalmologist.
What proven steps actually support eye health with age?
The best-supported measures are regular comprehensive eye exams to catch disease early, not smoking (smoking is a major risk factor for AMD and cataracts), managing blood pressure and blood sugar (critical for retinal vessels), UV protection with sunglasses, and a diet rich in leafy greens and omega-3s. For intermediate dry AMD specifically, the AREDS2 formula has trial evidence. Managing screen-related dryness with breaks and lubricating drops helps the ocular surface. These fundamentals do more for long-term eye health than any research peptide.
Are these peptides approved eye medications anywhere?
None of them is an approved consumer eye medication in major markets. Thymosin beta-4 and SS-31 have been studied as ophthalmic investigational drugs but are not general-market eye treatments, and BPC-157 and GHK-Cu are sold as research compounds rather than ophthalmic products. Because they are not manufactured or regulated as sterile eye medicines, using them on the eye is both off-label and potentially unsafe. Approved eye treatments exist for the major conditions people worry about, and those should be the starting point with an eye-care professional.

Other peptide Ingredient Combinations

The Anti-Aging Stack: GHK-Cu + Epitalon

GHK-Cu and Epitalon target two distinct hallmarks of aging — extracellular matrix degradation and te

The Athletic Performance Stack: IGF-1 LR3 + Ipamorelin + BPC-157

The athletic performance stack layers three peptides with distinct but complementary mechanisms to s

The Autoimmune Stack: KPV + BPC-157 + Thymosin Alpha-1 + Low-Dose Naltrexone

A four-component protocol addressing autoimmune dysregulation through complementary immunomodulatory

The Bone Health Stack: BPC-157 + Abaloparatide + Collagen Peptides

A three-component protocol addressing bone mineral density and bone quality. Abaloparatide is a synt

The Cardiac Protection Stack: TB-500 + SS-31 + Humanin

A three-peptide cardiovascular support stack targeting myocardial repair (TB-500), mitochondrial car

The Cognitive Stack: Semax + Selank

The classic Russian nootropic peptide pairing. Semax (an ACTH 4-10 analog) enhances BDNF expression

The Detox Support Stack: BPC-157 + KPV + LL-37 + Larazotide

A four-peptide combination addressing gut barrier integrity, systemic inflammation, and antimicrobia

The Endurance Stack: MOTS-c + SS-31 + BPC-157 + AOD-9604

A community-derived peptide combination discussed by endurance athletes for mitochondrial capacity,

The Fat Loss Stack: Tesamorelin + CJC-1295/Ipamorelin

Tesamorelin and CJC-1295/Ipamorelin both target the GH axis but through complementary timing and rec

The Fertility Stack: Kisspeptin-10 + Gonadorelin + Oxytocin

A three-peptide protocol targeting the hypothalamic-pituitary-gonadal (HPG) axis at multiple levels.

The GH Stack: CJC-1295 + Ipamorelin

The dual-pathway growth-hormone stack. CJC-1295 (GHRH analog) opens the pituitary somatotroph; Ipamo

The Gut-Brain Stack: BPC-157 + KPV + Selank + Larazotide

A community-derived peptide combination built around the gut-brain axis — pairing intestinal barrier

The Gut Healing Stack: BPC-157 + KPV + Larazotide

The gut healing stack combines three peptides targeting distinct aspects of intestinal repair: BPC-1

The Hair Restoration Stack: GHK-Cu + Thymosin Beta-4

GHK-Cu and Thymosin Beta-4 (TB-500) target complementary mechanisms in hair follicle biology — coppe

The Healing Stack: BPC-157 + TB-500

The canonical regenerative-peptide pairing. BPC-157 and TB-500 operate through non-overlapping biolo

Immune Support Stack

A combination approach targeting immune function through three complementary mechanisms: adaptive im

The Joint Repair Stack: BPC-157 + Pentosan Polysulfate + TB-500

A comprehensive joint-repair protocol targeting all layers of joint pathology: BPC-157 for periartic

The Longevity Stack: Epitalon + MOTS-c + SS-31

Three peptides targeting different hallmarks of aging: Epitalon for telomerase activation and pineal

The Men's Hormone Stack: CJC-1295/Ipamorelin + Gonadorelin + Kisspeptin-10

A three-peptide protocol designed to optimize the male hormonal axis without exogenous testosterone.

The Menopause Support Stack: Kisspeptin-10 + Epitalon + BPC-157 + GHK-Cu

A community-derived peptide combination sometimes discussed for the constellation of complaints arou

The Metabolic Stack: GLP-1 + GHS

A newer 'metabolic recomposition' pairing some practitioners use: a GLP-1 agonist for appetite and t

The Mitochondrial Stack: SS-31 + MOTS-c + Humanin

Three mitochondria-targeted peptides addressing different aspects of mitochondrial dysfunction. SS-3

The Mood & Anxiety Stack: Selank + NA-Selank-Amidate + DSIP + Oxytocin

A four-peptide anxiolytic and mood-stabilizing protocol. Selank modulates GABA and serotonin signali

The Neuroprotection Stack: Cerebrolysin + Semax + Pinealon

The neuroprotection stack combines three neuropeptide approaches with complementary mechanisms — cer

The Nootropic Stack: Semax + Selank + GH-Axis Support

A three-tier nootropic peptide stack targeting cognitive performance through complementary mechanism

The Post-Surgery Recovery Stack: BPC-157 + TB-500 + Thymosin Alpha-1

The post-surgery recovery stack combines the established BPC-157 + TB-500 tissue-repair pairing with

The Sexual Health Stack: PT-141 + Kisspeptin-10

PT-141 and Kisspeptin-10 target complementary aspects of sexual function — central desire pathways a

The Skin Rejuvenation Stack: GHK-Cu + GH-Axis + Collagen

A multi-level skin rejuvenation protocol combining topical signaling (GHK-Cu), systemic GH-axis elev

The Sleep Stack: DSIP + Ipamorelin

DSIP (Delta Sleep-Inducing Peptide) and ipamorelin target complementary aspects of sleep optimizatio

The Stress Resilience Stack: Selank + DSIP + Semax

A three-peptide stack targeting different dimensions of the stress response: Selank for anxiolysis a

The Tendon Repair Stack: BPC-157 + TB-500 + GHK-Cu

A three-peptide protocol targeting tendon biology specifically. BPC-157 upregulates growth hormone r

The Thymic Regeneration Stack: Thymosin Alpha-1 + Thymalin + Thymulin

Three thymic peptides targeting the age-related involution of the thymus gland. Thymosin alpha-1 enh

The Vascular Health Stack: BPC-157 + SS-31 + Angiotensin-1-7 + MOTS-c

A theoretical peptide combination discussed for endothelial and circulatory support — pairing angiog

The Weight Loss Stack: Semaglutide/Tirzepatide + Tesamorelin

This weight loss stack combines GLP-1 receptor agonist therapy (semaglutide or tirzepatide) with the

The Women's Hormonal Stack: Kisspeptin + BPC-157 + Thymosin Alpha-1

A three-peptide combination addressing women's hormonal health through hypothalamic signaling restor

The Wound Care Stack: BPC-157 + GHK-Cu + TB-500 + Collagen Peptides

A four-component protocol covering the full wound healing cascade. BPC-157 promotes angiogenesis and

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.